In breast, gastric, prostate, colorectal, and glioma cancers, some studies have reported upregulation of IGFBP7 expression, while others have reported downregulation, indicating a dual role of IGFBP7 in cancer cell proliferation, progression, and prognosis (Lin et al., 2019). This evidence concerns the gene IGFBP7 and cancer.